AZ-12601011

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameAZ-12601011
Drug Alias NameAZ-12601011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActivin receptor-like kinase 4 inhibitorsActivin receptor type-1C inhibitorsTransforming growth factor beta receptor 1 inhibitors
TargetsActivin receptor-like kinase 4Activin receptor type-1CTransforming growth factor beta receptor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A